Influence of Matrix Metallopeptidase 9 on Beta-Amyloid Elimination Across the Blood-Brain Barrier
- 18 June 2019
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 56 (12) , 8296-8305
Abstract
No abstract availableKeywords
Funding Information
- National Institute on Aging (R01AG041971)
- U.S. Department of Veterans Affairs (I01BX002839)
This publication has 37 references indexed in Scilit:
- Endothelial LRP1 – A Potential Target for the Treatment of Alzheimer’s DiseasePharmaceutical Research, 2017
- Accelerated pericyte degeneration and blood–brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer’s diseaseJournal of Cerebral Blood Flow & Metabolism, 2015
- Apolipoprotein E Isoform-Specific Effects on Lipoprotein Receptor ProcessingNeuroMolecular Medicine, 2014
- Stimulation of the Retinoid X Receptor Facilitates Beta-Amyloid Clearance Across the Blood–Brain BarrierJournal of Molecular Neuroscience, 2012
- Apolipoprotein E controls cerebrovascular integrity via cyclophilin ANature, 2012
- Characterization and use of human brain microvascular endothelial cells to examine β-amyloid exchange in the blood-brain barrierCytotechnology, 2010
- Alzheimer's disease: strategies for disease modificationNature Reviews Drug Discovery, 2010
- The Role of Apolipoprotein E in Alzheimer's DiseaseNeuron, 2009
- Abeta(1–40)-induced secretion of matrix metalloproteinase-9 results in sAPPα release by association with cell surface APPNeurobiology of Disease, 2007
- Matrix metalloproteinase-9 in cerebral-amyloid-angiopathy-related hemorrhageJournal of the Neurological Sciences, 2005